Expression of OFA-iLRP on malignant hematologic cell lines
Cell line . | Type . | OFA-iLRP expression . |
|---|---|---|
| ARH77 | B-ALL | +++ |
| Balm-3 | B-ALL | ++ |
| Balm-5 | B-ALL | +++ |
| NALM 6 | B-ALL | ++ |
| REH | B-ALL | ++ |
| BJAB | B-cell lymphoma | ++ |
| CA46 | B-cell lymphoma | ++ |
| DAUDI | B-cell lymphoma | +++ |
| IM-9 | B-cell lymphoma | +++ |
| Karpas-422 | B-cell lymphoma | +++ |
| Mec-1 | B-cell lymphoma | +++ |
| Ramos | B-cell lymphoma | ++ |
| U-266 | Plasmocytoma | ++ |
| RPMI 8226 | Plasmocytoma | ++ |
| HS-Sultan | Plasmocytoma | +++ |
| Jurkat | T-ALL | ++ |
| MKB-1 | T-cell lymphoma | + |
| Molt-4 | T-ALL | ++ |
| K562 | Erythroleukemia | +++ |
| HL60 | AML | ++ |
| KG-1 | AML | +++ |
| ML-2 | AML | +++ |
| Mono-Mac-6 | AML | +++ |
| THP-1 | AML | ++ |
| Kasumi-1 | AML | +++ |
Cell line . | Type . | OFA-iLRP expression . |
|---|---|---|
| ARH77 | B-ALL | +++ |
| Balm-3 | B-ALL | ++ |
| Balm-5 | B-ALL | +++ |
| NALM 6 | B-ALL | ++ |
| REH | B-ALL | ++ |
| BJAB | B-cell lymphoma | ++ |
| CA46 | B-cell lymphoma | ++ |
| DAUDI | B-cell lymphoma | +++ |
| IM-9 | B-cell lymphoma | +++ |
| Karpas-422 | B-cell lymphoma | +++ |
| Mec-1 | B-cell lymphoma | +++ |
| Ramos | B-cell lymphoma | ++ |
| U-266 | Plasmocytoma | ++ |
| RPMI 8226 | Plasmocytoma | ++ |
| HS-Sultan | Plasmocytoma | +++ |
| Jurkat | T-ALL | ++ |
| MKB-1 | T-cell lymphoma | + |
| Molt-4 | T-ALL | ++ |
| K562 | Erythroleukemia | +++ |
| HL60 | AML | ++ |
| KG-1 | AML | +++ |
| ML-2 | AML | +++ |
| Mono-Mac-6 | AML | +++ |
| THP-1 | AML | ++ |
| Kasumi-1 | AML | +++ |
Cell surface staining of neoplastic cell lines was assessed by flow cytometry using the monoclonal anti-OFA-iLRP antibody. Intensity of staining is denoted as follows: (0) absent, (+) low, (++) medium, and (+++) high.